Auro Laboratories Ltd - 530233 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Company dossier
Auro Laboratories
BSE:AUROLAB · ISIN INE292C01011
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Auro Laboratories
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Auro Laboratories Ltd - 530233 - Regulation 36(1)(B) Of SEBI (LODR) Regulations, 2015BSE · annual report · pdf
Archived filing Auro Laboratories Ltd - 530233 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Archived filing Auro Laboratories Ltd - 530233 - Notice Of 37Th Annual General Meeting (AGM) Scheduled On Tuesday, August 11, 2026BSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Board Meeting Outcome for Outcome Of The Board Meeting Dated June 30, 2026BSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Board Meeting Outcome for Held On May 29, 2026BSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Results For The Year Ended March 31, 2026BSE · financial results · pdf
Source filing Auro Laboratories Ltd - 530233 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)BSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Board Meeting Intimation for Board Meeting To Be Held On May 29, 2026BSE · financial results · pdf
Source filing Auro Laboratories Ltd - 530233 - Receipt Of 'Certification Of Substances Department' From European Directorate For The Quality Of Medicines & Healthcare ('EDQM')BSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Receipt Of 'Certificate Of GMP Compliance Of A Manufacturer' From Swissmedic Swiss Agency For Therapeutic Products.BSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Announcement under Regulation 30 (LODR)-Credit RatingBSE · credit rating · pdf
Source filing Auro Laboratories Ltd - 530233 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Auro Laboratories Ltd - 530233 - Financial Results For The Quarter Ended December 31, 2025BSE · financial results · pdf
Source filing Auro Laboratories Ltd - 530233 - Board Meeting Outcome for Outcome Of The Board MeetingBSE · financial results · pdf
Source filing Auro Laboratories Ltd - 530233 - Board Meeting Intimation for Unaudited Financial Results For Quarter Ended December 31, 2025.BSE · financial results · pdf
Source filing Auro Laboratories Ltd - 530233 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Auro Laboratories Ltd - 530233 - Board Meeting Outcome for Outcome Of The Board Meeting Dated November 12, 2025BSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025BSE · financial results · pdf
Source filing Auro Laboratories Ltd - 530233 - Grant Of 'Certificate Of Good Manufacturing Practices' From World Health Organisation ('WHQ").BSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Board Meeting Intimation for Unaudited Financial Results Of The Company For Quarter And Half Year Ended September 30, 2025.BSE · financial results · pdf
Source filing Auro Laboratories Ltd - 530233 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Regulation 36(1)(B) Of SEBI (LODR) RegulationsBSE · annual report · pdf
Source filing Auro Laboratories Ltd - 530233 - Notice Of 36Th Annual General Meeting (AGM) Scheduled On Thursday, September 25, 2025BSE · exchange filing · pdf
Source filing Auro Laboratories Ltd - 530233 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Source filing